HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of differentially expressed long non-coding RNAs and mRNAs in orbital adipose/connective tissue of thyroid-associated ophthalmopathy.

Abstract
Extracellular matrix remodeling and orbital adipose/connective tissue expansion are two key features of thyroid-associated ophthalmopathy (TAO). Recent studies have indicated the critical role of long non-coding RNAs (lncRNAs) in the pathogenesis of ocular disorders. However, little is known about the roles of lncRNAs in orbital adipose/connective tissue of TAO. In this study, the profiles of lncRNAs and mRNAs in the orbital adipose/connective tissue of TAO were identified by RNA sequencing. A total of 809 differential lncRNAs and 607 differential mRNAs were identified, among which 52 genes were found to be significantly related to the extracellular matrix. Co-expression network analysis suggested that lncRNAs might regulate extracellular matrix remodeling in orbital adipose/connective tissue of TAO. Additionally, the target genes of lncRNAs involved in the lipid metabolism and cytokine-cytokine receptor interaction were also identified. These results may provide potential regulatory mechanisms of lncRNAs in the orbital adipose/connective tissue of TAO.
AuthorsLianqun Wu, Lei Li, Yu Liang, Xinxin Chen, Pei Mou, Guohua Liu, Xiantao Sun, Bing Qin, Shujie Zhang, Chen Zhao
JournalGenomics (Genomics) Vol. 113 Issue 1 Pt 2 Pg. 440-449 (01 2021) ISSN: 1089-8646 [Electronic] United States
PMID32919017 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020. Published by Elsevier Inc.
Chemical References
  • RNA, Long Noncoding
  • RNA, Messenger
Topics
  • Adipose Tissue (metabolism)
  • Adult
  • Connective Tissue (metabolism)
  • Eye (metabolism)
  • Female
  • Gene Regulatory Networks
  • Graves Ophthalmopathy (genetics, metabolism)
  • Humans
  • Male
  • Middle Aged
  • RNA, Long Noncoding (genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: